---
figid: PMC7937699__fimmu-12-623639-g0002
figtitle: 'From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting
  the Lessons From the Past'
organisms:
- Mus musculus
- Rattus norvegicus
- Danio rerio
- Toxoplasma gondii
- Patella vulgata
- Naja oxiana
- Homo sapiens
pmcid: PMC7937699
filename: fimmu-12-623639-g0002.jpg
figlink: pmc/articles/PMC7937699/figure/F2/
number: F2
caption: Represents the multiple positive-loops between programmed death-ligand 1
  (PD-L1), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), mucin 1 (MUC1), myeloid-derived
  suppressor cell (MDSC), dendritic cell (DC), T-cell, the MAPK signaling pathway,
  and the PI3K/AKT pathway. The immunosuppressive microenvironment is partially due
  to these unfavorable auto-inductive loops. The PD-L1/PD-1 axis is a well-established
  culprit of impeding anti-tumoral immune response development. The CTLA-4/CD80, CD86,
  another immune checkpoint axis, is responsible for suppressing the anti-tumoral
  immune response. The PD-L1 on the tumoral cell surface can impede the development
  of the anti-tumoral immune response and stimulated the PI3K/Akt and MAPK signaling
  pathways. MUC1 has the focal role in the recruitment of MDSC and the propelling
  of the MAPK pathway. The MAPK signaling pathway is also responsible for the overexpression
  of MUC1. Thus, these positive loops can substantially induce an immunosuppressive
  micro-environment. Therefore, these two major recognized signaling pathways can
  induce tumorigenesis and shield the tumoral cells from anti-tumoral immune responses.
papertitle: 'From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting
  the Lessons From the Past.'
reftext: Mahdi Abdoli Shadbad, et al. Front Immunol. 2021;12:623639.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7731844
figid_alias: PMC7937699__F2
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Danio rerio
redirect_from: /figures/PMC7937699__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7937699__fimmu-12-623639-g0002.html
  '@type': Dataset
  description: Represents the multiple positive-loops between programmed death-ligand
    1 (PD-L1), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), mucin 1 (MUC1),
    myeloid-derived suppressor cell (MDSC), dendritic cell (DC), T-cell, the MAPK
    signaling pathway, and the PI3K/AKT pathway. The immunosuppressive microenvironment
    is partially due to these unfavorable auto-inductive loops. The PD-L1/PD-1 axis
    is a well-established culprit of impeding anti-tumoral immune response development.
    The CTLA-4/CD80, CD86, another immune checkpoint axis, is responsible for suppressing
    the anti-tumoral immune response. The PD-L1 on the tumoral cell surface can impede
    the development of the anti-tumoral immune response and stimulated the PI3K/Akt
    and MAPK signaling pathways. MUC1 has the focal role in the recruitment of MDSC
    and the propelling of the MAPK pathway. The MAPK signaling pathway is also responsible
    for the overexpression of MUC1. Thus, these positive loops can substantially induce
    an immunosuppressive micro-environment. Therefore, these two major recognized
    signaling pathways can induce tumorigenesis and shield the tumoral cells from
    anti-tumoral immune responses.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ido1
  - Pik3cg
  - Vegfa
  - Ephb1
  - Il6
  - Il10
  - Mtor
  - Ctla4
  - Muc1
  - Cd28
  - Cd86
  - Cd80
  - Pik3r1
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - Cd274
  - Pdcd1
  - Hc
  - Trav6-3
  - IDO1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - EPHB2
  - MAPK1
  - MAPK3
  - IL6
  - IL10
  - MTOR
  - CD274
  - CTLA4
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - TGFA
  - MUC1
  - CD28
  - CD86
  - CD80
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - ido1
  - rab1ab
  - vegfaa
  - il6
  - il10
  - mtor
  - kita
  - ngfra
  - pak2a
  - itpka
  - si:ch211-241b2.5
  - cd28
  - tyrosine
  - TCR
---
